lung infection in a preliminary phase 1 clinical trial. These findings raise the possibility that human infections could be treated by targeting iron metabolism or other nutritional vulnerabilities of bacterial pathogens.
Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections | Litlas